Yusuf Yilmaz1,2, Fatih Eren3,2. 1. Departments of Gastroenterology. 2. Institute of Gastroenterology, Marmara University, Istanbul, Turkey. 3. Medical Biology, School of Medicine.
Abstract
BACKGROUND: We sought to explore the interplay of multiple serum biomarkers of fibrosis and extracellular matrix remodeling with the results of liver histology in patients with nonalcoholic fatty liver disease (NAFLD). PATIENTS AND METHODS: Venous blood samples were collected from 80 patients with biopsy-proven NAFLD and 59 age-matched and sex-matched healthy controls. Serum levels of transforming growth factor (TGF)-β1, TGF-β2, matrix metalloproteinases (MMP)-1, MMP-2, MMP-7, MMP-9, MMP-10, tissue inhibitors of metalloproteinase (TIMP)-1, and TIMP-2 were determined by using the Luminex MagPix technology on a MAGPIX analyzer. RESULTS: We documented significant differences in the levels of TGF-β1, TGF-β2, MMP-2, MMP-7, MMP-9, TIMP-1, and TIMP-2 between NAFLD patients and controls. However, none of these biomarkers was able to distinguish between nonalcoholic steatohepatitis and nonalcoholic fatty liver. TIMP-1 levels were significantly higher in patients with significant fibrosis (fibrosis stage ≥2; 2624±1261 pg/ml) than in those without (fibrosis stage 0-1; 2096±906 pg/ml; P=0.03). Moreover, serum levels of TIMP-1 were identified as the only independent predictor of histological fibrosis (β=0.298, t=2.7, P=0.007). CONCLUSION: Our study provides insights into the association of multiple serum biomarkers of fibrosis and extracellular matrix remodeling with NAFLD histology. Notably, serum levels of TIMP-1 were identified as a clinically useful marker for distinguishing NAFLD patients with and without significant fibrosis.
BACKGROUND: We sought to explore the interplay of multiple serum biomarkers of fibrosis and extracellular matrix remodeling with the results of liver histology in patients with nonalcoholic fatty liver disease (NAFLD). PATIENTS AND METHODS: Venous blood samples were collected from 80 patients with biopsy-proven NAFLD and 59 age-matched and sex-matched healthy controls. Serum levels of transforming growth factor (TGF)-β1, TGF-β2, matrix metalloproteinases (MMP)-1, MMP-2, MMP-7, MMP-9, MMP-10, tissue inhibitors of metalloproteinase (TIMP)-1, and TIMP-2 were determined by using the Luminex MagPix technology on a MAGPIX analyzer. RESULTS: We documented significant differences in the levels of TGF-β1, TGF-β2, MMP-2, MMP-7, MMP-9, TIMP-1, and TIMP-2 between NAFLD patients and controls. However, none of these biomarkers was able to distinguish between nonalcoholic steatohepatitis and nonalcoholic fatty liver. TIMP-1 levels were significantly higher in patients with significant fibrosis (fibrosis stage ≥2; 2624±1261 pg/ml) than in those without (fibrosis stage 0-1; 2096±906 pg/ml; P=0.03). Moreover, serum levels of TIMP-1 were identified as the only independent predictor of histological fibrosis (β=0.298, t=2.7, P=0.007). CONCLUSION: Our study provides insights into the association of multiple serum biomarkers of fibrosis and extracellular matrix remodeling with NAFLD histology. Notably, serum levels of TIMP-1 were identified as a clinically useful marker for distinguishing NAFLD patients with and without significant fibrosis.
Authors: Henrik H Hansen; Helene M Ægidius; Denise Oró; Simon S Evers; Sara Heebøll; Peter Lykke Eriksen; Karen Louise Thomsen; Anja Bengtsson; Sanne S Veidal; Michel Feigh; Malte P Suppli; Filip K Knop; Henning Grønbæk; Diego Miranda; James L Trevaskis; Niels Vrang; Jacob Jelsing; Kristoffer T G Rigbolt Journal: BMC Gastroenterol Date: 2020-07-06 Impact factor: 3.067
Authors: Hannah L Paish; Lee H Reed; Helen Brown; Mark C Bryan; Olivier Govaere; Jack Leslie; Ben S Barksby; Marina Garcia Macia; Abigail Watson; Xin Xu; Marco Y W Zaki; Laura Greaves; Julia Whitehall; Jeremy French; Steven A White; Derek M Manas; Stuart M Robinson; Gabriele Spoletini; Clive Griffiths; Derek A Mann; Lee A Borthwick; Michael J Drinnan; Jelena Mann; Fiona Oakley Journal: Hepatology Date: 2019-05-28 Impact factor: 17.425
Authors: Joanna B Trojanek; Jacek Michałkiewicz; Renata Grzywa-Czuba; Wojciech Jańczyk; Lidia Gackowska; Izabela Kubiszewska; Anna Helmin-Basa; Aldona Wierzbicka-Rucińska; Mieczysław Szalecki; Piotr Socha Journal: Mediators Inflamm Date: 2020-09-10 Impact factor: 4.711